MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
+23.87%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$209M
AUM Growth
+$209M
(+29%)
Cap. Flow
+$17.3M
Cap. Flow
% of AUM
8.25%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
CMPI
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
|
$17.3M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vaxcyte
PCVX
$4B
| $93.2M | 44.51% | 1,887,478 | – | – |
|
2
Phathom Pharmaceuticals
PHAT
$864M
| $75.8M | 36.21% | 2,067,861 | – | – |
|
3
Merus
MRUS
$4.98B
| $19.2M | 9.17% | 1,600,000 | – | – |
|
|
CMPI
4
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $17.3M | 8.25% | +1,501,716 | New | +$17.3M |
|
|
OBSV
5
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $3.89M | 1.86% | 1,570,000 | – | – |
|